期刊文献+

人工髋关节置换术后无菌性松动防治研究进展

Research Progress in Prevention and Treatment of Aseptic Loosening after Total Hip Arthroplasty
下载PDF
导出
摘要 假体无菌性松动是人工髋关节置换术后的主要并发症,其标志着全髋关节假体的失败。假体无菌性松动是多因素、多机制参与的过程,早期无菌性松动患者往往无明显症状,易漏诊、误诊。因此,更好地认识无菌松动的复杂发生机制、疾病特点和防治手段将有利于降低该并发症的发生率,有助于无菌性松动的早发现、早诊断、早治疗。文章对人工髋关节置换术后假体无菌性松动的发生机制、症状及体征、治疗与预防方案的进展作一综述。 Aseptic loosening of prosthesis is a major complication after total hip arthroplasty, which marks the failure of total hip prosthesis. Aseptic loosening of prostheses is a process involving multiple factors and mechanisms. Patients with early aseptic loosening often have no obvious symptoms, and are prone to missed diagnosis and misdiagnosis. Therefore, a better understanding of the complex pathogenesis, disease characteristics and prevention and treatment of aseptic loosening will help to reduce the incidence of this complication and help to early detect, diagnose and treat aseptic loosening. This article reviews the progress in the mechanism, symptoms, signs,treatment and prevention of aseptic loosening of prostheses after hip replacement.
出处 《大众科技》 2023年第1期102-105,共4页 Popular Science & Technology
关键词 无菌性松动 发生机制 防治策略 aseptic loosening occurrence mechanism prevention strategies
  • 相关文献

参考文献11

二级参考文献79

  • 1蔡春水,肖平,张毅,赵新建,林爱珍.骨碎补总黄酮对巨噬细胞分泌细胞因子TNF-α、IL-6水平的影响[J].中国矫形外科杂志,2006,14(15):1185-1187. 被引量:25
  • 2王婷,张大威,张金超,杨梦甦,肖培根.淫羊藿黄酮的分离鉴定及其对前破骨细胞株增殖的影响[J].中草药,2006,37(10):1458-1462. 被引量:43
  • 3耿小平,孙昀.切口裂开的预防与处理[J].中国实用外科杂志,2007,27(1):45-47. 被引量:33
  • 4Jazrawi LM,Kummer FJ,Di Cesare PE,et al.Alternative bearing surfaces for total joint arthroplasty[J].J Am Acad Orthop Surg,1998,6(4):198-203.
  • 5Neale SD,Sabokbar A,Howie DW,et al.Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption[J].J Orthop Res,1999,17(5):686-694.
  • 6Purdue PE,Koulouvaris P,Potter HG,et al.The cellular and molecular biology of periprosthetic osteolysis[J].Clin Orthop Relat Res,2007,454:251-261.
  • 7Wada T,Nakashima T,Hiroshi N,et al.RANKL-RANK signaling in osteoclastogenesis and bone disease[J].Trends Mol Med,2006,12(1):17-25.
  • 8Lomaga MA,Yeh WC,Sarosi I,et al.TRAF6 deficiency results in osteopetrosis and defective interleukin-1,CD40,and LPS signaling[J].Genes Dev,1999,13(8):1015-1024.
  • 9Chan RY,Chen WF,Dong A,et al.Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng[J].J Clin Endocrinol Metab,2002,87(8):3691-3695.
  • 10Xu QF,Fang XL,Chen DF,et al.Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats[J].J Ethnopharmacol,2003,84(2-3):187-192.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部